Furthermore, we demonstrated higher kallikrein 6 levels in CAKs, which is in line with the findings of Krenzer et al., who described that it is produced by melanoma-adjacent keratinocytes, and supports tumor cell migration and invasion [61]. The gene discussed is KLK6; the disease is melanoma.